System1 Biosciences is a company discovering drugs for brain diseases using human cerebral organoids. It leverages AI-driven phenotypic screening, cerebral organoid science, systems neuroscience, robotic automation, and data analytics to identify novel therapeutic targets and drug treatments for epilepsy, autism, schizophrenia, etc.
|HQ||San Francisco, CA, US||Map|
|Employees (est.) (May 2020)||37||(-11%)|
System1 Biosciences total Funding
System1 Biosciences latest funding size
Time since last funding
|3 years ago|
System1 Biosciences investors
|CRV, Webb Investment Network, Dolby Family Ventures, Pfizer Venture Investments, Wilmont Ventures, Liquid 2 Ventures, The Longevity Fund, Courtney Broadus, Riot Ventures, Kinled Holding|
System1 Biosciences has 16 Twitter Followers. The number of followers has increased 6.7% month over month and increased 10.1% quarter over quarter
When was System1 Biosciences founded?
System1 Biosciences was founded in 2017.
Who are System1 Biosciences key executives?
System1 Biosciences's key executives are Gaia Skibinski, Saul Kato and Daniel Chao.
How many employees does System1 Biosciences have?
System1 Biosciences has 37 employees.
Who are System1 Biosciences competitors?
Competitors of System1 Biosciences include Finch Therapeutics, Unnatural Products and Xbiome.
Where is System1 Biosciences headquarters?
System1 Biosciences headquarters is located at 1405 Minnesota St, San Francisco, San Francisco.
Where are System1 Biosciences offices?
System1 Biosciences has an office in San Francisco.
How many offices does System1 Biosciences have?
System1 Biosciences has 2 offices.
Receive alerts for 300+ data fields across thousands of companies